Fig. 2From: Risk of chronic kidney disease in patients with gout and the impact of urate lowering therapy: a population-based cohort studyDevelopment of chronic kidney disease (CKD) stage ≥ 3 in patients with gout and patients without gout (non-gout) during follow upBack to article page